BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19527630)

  • 1. [Tumoral angiogenesis: models, targets and inhibition].
    Bikfalvi A
    J Soc Biol; 2009; 203(2):167-70. PubMed ID: 19527630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amifostine inhibits angiogenesis in vivo.
    Giannopoulou E; Katsoris P; Kardamakis D; Papadimitriou E
    J Pharmacol Exp Ther; 2003 Feb; 304(2):729-37. PubMed ID: 12538828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [VEGF, anti-vEGF and diseases].
    Corvol P
    Bull Acad Natl Med; 2008 Feb; 192(2):289-300; discussion 300-2. PubMed ID: 18819684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chick embryo chorioallantoic membrane in the study of tumor angiogenesis.
    Ribatti D
    Rom J Morphol Embryol; 2008; 49(2):131-5. PubMed ID: 18516317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenesis and anticancer efficacy of TA138, a novel alphavbeta3 antagonist.
    Mousa SA; Mohamed S; Wexler EJ; Kerr JS
    Anticancer Res; 2005; 25(1A):197-206. PubMed ID: 15816539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of recombinant adenovirus-mediated triple mutant of hypoxia inducible factor-1alpha in modulating angiogenesis].
    Wei X; Tao Y; Pei JX; Li MY; Chen JW; Liu C; Wu PS
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):686-9. PubMed ID: 20423826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis: an organizing principle for drug discovery?
    Folkman J
    Nat Rev Drug Discov; 2007 Apr; 6(4):273-86. PubMed ID: 17396134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.
    Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; BĂ©liveau R; Luis J
    J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of angiogenesis by a novel small peptide consisting of the active fragments of platelet factor-4 and vasostatin.
    Li X; Jiang L; Wang Y; Xiao Y; Huang Y; Yao Q; Yang Y; Wu X
    Cancer Lett; 2007 Oct; 256(1):29-32. PubMed ID: 17574330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral serpin, Serp-1, inhibits endogenous angiogenesis in the chicken chorioallantoic membrane model.
    Richardson M; Liu L; Dunphy L; Wong D; Sun Y; Viswanathan K; Singh G; Lucas A
    Cardiovasc Pathol; 2007; 16(4):191-202. PubMed ID: 17637427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of growth and cancer-induced angiogenesis of aggressive human breast cancer cells (MDA-MB-231) on the chorioallantoic membrane of developing chicken embryos by E-peptide of pro-IGF-I.
    Chen MJ; Chiou PP; Lin P; Lin CM; Siri S; Peck K; Chen TT
    J Cell Biochem; 2007 Aug; 101(5):1316-27. PubMed ID: 17286280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in understanding angiogenesis through molecular studies.
    Kwon M; Libutti SK
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):26-32. PubMed ID: 16377412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental approaches to study in vivo angiogenesis].
    Kilarski W; Bikfalvi A
    Bull Cancer; 2007 Jul; 94 Spec No():S166-9. PubMed ID: 17846001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic hypoxic cytotoxin TX-402 inhibits hypoxia-inducible factor 1 signaling pathway.
    Nagasawa H; Mikamo N; Nakajima Y; Matsumoto H; Uto Y; Hori H
    Anticancer Res; 2003; 23(6a):4427-34. PubMed ID: 14666730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gelatin sponge-chorioallantoic membrane assay.
    Ribatti D; Nico B; Vacca A; Presta M
    Nat Protoc; 2006; 1(1):85-91. PubMed ID: 17406216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated endoplasmic reticulum stress responses in cancer.
    Moenner M; Pluquet O; Bouchecareilh M; Chevet E
    Cancer Res; 2007 Nov; 67(22):10631-4. PubMed ID: 18006802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of the hypoxia-inducible factor system by low levels of heat shock protein 90 inhibitors.
    Ibrahim NO; Hahn T; Franke C; Stiehl DP; Wirthner R; Wenger RH; Katschinski DM
    Cancer Res; 2005 Dec; 65(23):11094-100. PubMed ID: 16322259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baicalein induces functional hypoxia-inducible factor-1alpha and angiogenesis.
    Cho H; Lee HY; Ahn DR; Kim SY; Kim S; Lee KB; Lee YM; Park H; Yang EG
    Mol Pharmacol; 2008 Jul; 74(1):70-81. PubMed ID: 18426858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
    Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
    Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin.
    Komi Y; Ohno O; Suzuki Y; Shimamura M; Shimokado K; Umezawa K; Kojima S
    Jpn J Clin Oncol; 2007 Nov; 37(11):867-73. PubMed ID: 17956898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.